OMER vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

OMER

65.5
AI Score
VS
OMER Wins

ZBIO

49.9
AI Score

Investment Advisor Scores

OMER

66score
Recommendation
BUY

ZBIO

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric OMER ZBIO Winner
Forward P/E 87.7193 0 Tie
PEG Ratio 0.8053 0 Tie
Revenue Growth 14.9% -100.0% OMER
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 65.5/100 49.9/100 OMER
Profit Margin 324.9% 0.0% OMER
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD OMER

Relative Price Performance (Last 90 Days)

OMER 1M: -17.7% · 3M: +46.1% ZBIO 1M: -2.3% · 3M: -18.1%

Current Technical Phase

OMER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.3 · Price: $16.57

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $26.87

Fundamentals Snapshot

Metric OMER ZBIO
Market Cap — —
Forward P/E 13.5 -5.8
Trailing P/E 13.3 —
Revenue (TTM) — —
Revenue Growth 0.1% -1.0%
Gross Margin 0.4% -212.5%
Operating Margin 0.0% -77.7%
EPS 1.27 -9.68
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OMER is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.